Dear all:
The Food and Drug Administration (FDA) and the International Society of
Pharmacometrics (ISoP) will jointly convene a workshop on MIDD for oncology
products on Feb 1, 2018. This is the first workshop to fulfill the
Model-Informed Drug Development (MIDD) commitment under PDUFA VI. The workshop
is free and can be accessed remotely after you register. The detailed
information can be found here:
https://www.fda.gov/Drugs/NewsEvents/ucm589449.htm
Thanks
Yaning Wang, Ph.D.
Director
Division of Pharmacometrics
Office of Clinical Pharmacology
Office of Translational Sciences
Center for Drug Evaluation and Research
Food and Drug Administration
Phone: 301-796-1624
Email: [email protected]
Disclaimer: The contents of this message are mine personally and do not
necessarily reflect any position of the Government or the Food and Drug
Administration.